Case number 1:20-cv-00793
Astellas US LLC et al v. USV Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 13, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. 566 in 18-1675-CFC/CJB. (fms) |
| Sep 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz filed by USV Private Limited. Signed by Judge Colm F. Connolly on 9/16/2020. (nmf) |
| Sep 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-00793-CFC) STIPULATION AND ORDER to Consolidate Action with 18-1675 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. The discovery limits and Scheduling Order entered in 18-1675-CFC shall apply with modifications as outlined in the stipulation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1675-CFC ONLY. Signed by Judge Colm F. Connolly on 9/16/2020. Associated Cases: 1:20-cv-00793-CFC, 1:18-cv-01675-CFC-CJB(nmf) |
| Sep 16, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC-CJB. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1675-CFC-CJB ONLY. (nmf) |
| Sep 15, 2020 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Amendd First Set of Common RFPs (Nos. 1-30); Third Amended Second Set of Common RFPs (No. 31); Fourth Amended First Set of Common Interrogatries (Nos. 1-11); Second Amended Second Set of Common Interrogatories (Nos. 12-15); First Amended First Set of Common RFAs (Nos. 1-24); Individual Interrogatories (Nos. 1-2) First Set of RFAs (Nos. 1-19) and First Set of Authentication RFAs (Nos. 1-34) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 15, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by USV Private Limited. (Dorsney, Kenneth) |
| Sep 14, 2020 | 13 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) USV Private Limited 's First Set of Individual Requests for Production (NOS. 1-13); (2) USV Private Limited's First Set of Individual Interrogatories (NOS. 1-9) filed by USV Private Limited.(Dorsney, Kenneth) |
| Sep 14, 2020 | 14 | Notice (Other) (2) Docket Text: NOTICE of Joinder in Defendants' Initial Invalidity Contentions by USV Private Limited (Dorsney, Kenneth) |
| Sep 14, 2020 | 15 | Stipulation (6) Docket Text: STIPULATION Consolidate Action with 18-1675 by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 20, 2020 | 12 | Order (1) Docket Text: ORDER, IT IS ORDERED that, on or before September 18, 2020, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 9/18/2020.) Signed by Judge Colm F. Connolly on 8/19/2020. (nmf) |
| Aug 7, 2020 | 11 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) USV Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) USV Private Limited's Paragraph 3 Disclosures filed by USV Private Limited.(Dorsney, Kenneth) |
| Jul 20, 2020 | 10 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 6, 2020 | 8 | Answer to Complaint (14) Docket Text: ANSWER to [1] Complaint, by USV Private Limited.(Dorsney, Kenneth) |
| Jul 6, 2020 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by USV Private Limited. (Dorsney, Kenneth) |
| Jun 17, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jun 15, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. USV Private Limited served on 6/12/2020, answer due 7/6/2020. (Oakes, Robert) |
| Jun 11, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Jun 11, 2020 | 1 | Exhibit A (22) |
| Jun 11, 2020 | 1 | Exhibit B (22) |
| Jun 11, 2020 | 1 | Exhibit C (20) |
| Jun 11, 2020 | 1 | Exhibit D (18) |
| Jun 11, 2020 | 1 | Civil Cover Sheet (1) |
| Jun 11, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 11, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/13/2020. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 11/13/2022. (nmg) |
| Jun 11, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (nmg) |
| Jun 11, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Jun 11, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) |
